SCHEMBL7125922

SCHEMBL7125922

O=C(Nc1ccc(S(=O)(=O)NN2CCCCC2)cc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.64
MEN1 O00255 5/20 0.64
MAPT P10636 5/20 0.58
MAPK1 P28482 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
CYP3A4 P08684 2/20 0.58
PPARG P37231 2/20 0.58
RORC P51449 2/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
PKM P14618 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
CYP2C19 P33261 1/20 0.58
THPO P40225 1/20 0.58
MTOR P42345 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132443 0.86 MEN1 (0.81) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7120981 0.85 MEN1 (0.82) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7120574 0.82 KMT2A (0.62) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7128789 0.82 MAPT (0.81) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7128371 0.80 KMT2A (0.62) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7130609 0.80 RORC (0.84) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7129858 0.79 MAPT (0.77) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7119693 0.79 MAPT (0.63) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7128804 0.79 MEN1 (0.74) KMT2AMEN1MAPTMAPK1SMN1; SMN2
SCHEMBL7129116 0.78 KMT2A (1.00) KMT2AMEN1MAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD KMT2A 3291/4885MEN1 4865/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.